Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Receptor Tyrosine Protein Kinase ERBB 3 market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Receptor Tyrosine Protein Kinase ERBB 3 market segmented into
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others
Based on the end-use, the global Receptor Tyrosine Protein Kinase ERBB 3 market classified into
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others
Based on geography, the global Receptor Tyrosine Protein Kinase ERBB 3 market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RECEPTOR TYROSINE PROTEIN KINASE ERBB 3 INDUSTRY
2.1 Summary about Receptor Tyrosine Protein Kinase ERBB 3 Industry
2.2 Receptor Tyrosine Protein Kinase ERBB 3 Market Trends
2.2.1 Receptor Tyrosine Protein Kinase ERBB 3 Production & Consumption Trends
2.2.2 Receptor Tyrosine Protein Kinase ERBB 3 Demand Structure Trends
2.3 Receptor Tyrosine Protein Kinase ERBB 3 Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 BA-0702
4.2.2 CDX-3379
4.2.3 Elgemtumab
4.2.4 ETBX-031
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Non-Small Cell Carcinoma
4.3.2 Solid Tumor
4.3.3 Melanoma
4.3.4 Colorectal Cancer
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 BA-0702
5.2.2 CDX-3379
5.2.3 Elgemtumab
5.2.4 ETBX-031
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Non-Small Cell Carcinoma
5.3.2 Solid Tumor
5.3.3 Melanoma
5.3.4 Colorectal Cancer
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 BA-0702
6.2.2 CDX-3379
6.2.3 Elgemtumab
6.2.4 ETBX-031
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Non-Small Cell Carcinoma
6.3.2 Solid Tumor
6.3.3 Melanoma
6.3.4 Colorectal Cancer
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 BA-0702
7.2.2 CDX-3379
7.2.3 Elgemtumab
7.2.4 ETBX-031
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Non-Small Cell Carcinoma
7.3.2 Solid Tumor
7.3.3 Melanoma
7.3.4 Colorectal Cancer
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 BA-0702
8.2.2 CDX-3379
8.2.3 Elgemtumab
8.2.4 ETBX-031
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Non-Small Cell Carcinoma
8.3.2 Solid Tumor
8.3.3 Melanoma
8.3.4 Colorectal Cancer
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 BA-0702
9.2.2 CDX-3379
9.2.3 Elgemtumab
9.2.4 ETBX-031
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Non-Small Cell Carcinoma
9.3.2 Solid Tumor
9.3.3 Melanoma
9.3.4 Colorectal Cancer
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AstraZeneca Plc
10.1.2 AVEO Pharmaceuticals, Inc.
10.1.3 Etubics Corporation
10.1.4 F. Hoffmann-La Roche Ltd.
10.1.5 GamaMabs Pharma S.A.
10.1.6 GlaxoSmithKline Plc
10.1.7 Hanmi Pharmaceuticals, Co. Ltd.
10.1.8 ImmunoGen, Inc.
10.1.9 Kolltan Pharmaceuticals, Inc.
10.1.10 Merrimack Pharmaceuticals, Inc.
10.1.11 Merus B.V.
10.1.12 Novartis AG
10.1.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
10.1.14 Sihuan Pharmaceutical Holdings Group Ltd.
10.1.15 Sorrento Therapeutics, Inc.
10.1.16 Symphogen A/S
10.1.17 Takis S.r.l.
10.2 Receptor Tyrosine Protein Kinase ERBB 3 Sales Date of Major Players (2017-2020e)
10.2.1 AstraZeneca Plc
10.2.2 AVEO Pharmaceuticals, Inc.
10.2.3 Etubics Corporation
10.2.4 F. Hoffmann-La Roche Ltd.
10.2.5 GamaMabs Pharma S.A.
10.2.6 GlaxoSmithKline Plc
10.2.7 Hanmi Pharmaceuticals, Co. Ltd.
10.2.8 ImmunoGen, Inc.
10.2.9 Kolltan Pharmaceuticals, Inc.
10.2.10 Merrimack Pharmaceuticals, Inc.
10.2.11 Merus B.V.
10.2.12 Novartis AG
10.2.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
10.2.14 Sihuan Pharmaceutical Holdings Group Ltd.
10.2.15 Sorrento Therapeutics, Inc.
10.2.16 Symphogen A/S
10.2.17 Takis S.r.l.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Type Overview
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Type Market Share List
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Type of Major Players
Table Brief Introduction of AstraZeneca Plc
Table Brief Introduction of AVEO Pharmaceuticals, Inc.
Table Brief Introduction of Etubics Corporation
Table Brief Introduction of F. Hoffmann-La Roche Ltd.
Table Brief Introduction of GamaMabs Pharma S.A.
Table Brief Introduction of GlaxoSmithKline Plc
Table Brief Introduction of Hanmi Pharmaceuticals, Co. Ltd.
Table Brief Introduction of ImmunoGen, Inc.
Table Brief Introduction of Kolltan Pharmaceuticals, Inc.
Table Brief Introduction of Merrimack Pharmaceuticals, Inc.
Table Brief Introduction of Merus B.V.
Table Brief Introduction of Novartis AG
Table Brief Introduction of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Table Brief Introduction of Sihuan Pharmaceutical Holdings Group Ltd.
Table Brief Introduction of Sorrento Therapeutics, Inc.
Table Brief Introduction of Symphogen A/S
Table Brief Introduction of Takis S.r.l.
Table Products & Services of AstraZeneca Plc
Table Products & Services of AVEO Pharmaceuticals, Inc.
Table Products & Services of Etubics Corporation
Table Products & Services of F. Hoffmann-La Roche Ltd.
Table Products & Services of GamaMabs Pharma S.A.
Table Products & Services of GlaxoSmithKline Plc
Table Products & Services of Hanmi Pharmaceuticals, Co. Ltd.
Table Products & Services of ImmunoGen, Inc.
Table Products & Services of Kolltan Pharmaceuticals, Inc.
Table Products & Services of Merrimack Pharmaceuticals, Inc.
Table Products & Services of Merus B.V.
Table Products & Services of Novartis AG
Table Products & Services of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Table Products & Services of Sihuan Pharmaceutical Holdings Group Ltd.
Table Products & Services of Sorrento Therapeutics, Inc.
Table Products & Services of Symphogen A/S
Table Products & Services of Takis S.r.l.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (Million USD) by Region 2021f-2026f
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-0702 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CDX-3379 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elgemtumab Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ETBX-031 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-Small Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-0702 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CDX-3379 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elgemtumab Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ETBX-031 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-Small Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-0702 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CDX-3379 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elgemtumab Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ETBX-031 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-Small Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-0702 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CDX-3379 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elgemtumab Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ETBX-031 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-Small Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-0702 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CDX-3379 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elgemtumab Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ETBX-031 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-Small Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BA-0702 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CDX-3379 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Elgemtumab Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ETBX-031 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-Small Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid Tumor Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of AstraZeneca Plc 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of AVEO Pharmaceuticals, Inc. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Etubics Corporation 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of F. Hoffmann-La Roche Ltd. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of GamaMabs Pharma S.A. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of GlaxoSmithKline Plc 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Hanmi Pharmaceuticals, Co. Ltd. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of ImmunoGen, Inc. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Kolltan Pharmaceuticals, Inc. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Merrimack Pharmaceuticals, Inc. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Merus B.V. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Novartis AG 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Sihuan Pharmaceutical Holdings Group Ltd. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Sorrento Therapeutics, Inc. 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Symphogen A/S 2017-2020e
Figure Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue (Million USD) of Takis S.r.l. 2017-2020e